2014年
Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. J Neurol Neurosurg Psychiatry, 2014, in press.
Hayashi Y, Higashi T, Motoyama K, Mori Y, Jono H, Ando Y, Arima H. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, a-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo. J Drug Target, 2014, in press.
Nakamura T, Migita K, Ando Y, Takaoka H, Suzushima H, Shiraishi N. Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. Mod Rheumatol 24: 39-52, 2014.
2013年
Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici
L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F: Guideline of transthyretin-related
hereditary amyloidosis for clinicians. Orphanet J Rare Dis 8, E-pub, 2013.
Misumi Y, Ando Y, Gonçalves NP, Saraiva MJ. Fibroblasts endocytose and
degrade transthyretin aggregates in transthyretin-related amyloidosis.
Lab Invest 93: 911-920, 2013.
Obayashi K, Misumi Y, Watanabe T, Ando T, Akagami T, Tasaki M, Shinriki S, Ueda M, Yamashita T, Hirotani S, Ando Y. Dominant cardiac type of familial amyloidotic polyneuropathy associated with a novel transthyretin variant Thr59Arg. Muscle Nerve: 48 839-841, 2013.
Obayashi K, Tasaki M, Jono H, Ueda M, Shinriki S, Misumi Y, Yamashita T,
Oshima T, Nakamura T, Ikemizu S, Anan I, Suhr O, Ando Y. Impact of antibodies
against amyloidogenic transthyretin (ATTR) on phenotypes of patients with
familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine. Clin
Chim Acta 419: 127-131, 2013.
Obayashi K. Salivary mental stress proteins. Clin Chim Acta 425: 196-201,
2013.
Ogasawara N, Kitagawa W, Obayashi K, Itoh Y, Noda H, Funaki Y, Yokoi T, Sasaki M, Imai H, Kasugai K. Solitary amyloidosis of the sigmoid colon featuring submucosal tumor caused hematochezia Intern Med 52: 2523-2527, 2013.
Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi
T, Asonuma K, Ando Y, Inomata Y. Peritransplant Gastrointestinal Symptoms
in Familial Amyloidotic Polyneuropathy. Exp Clin Transplant, 11: 327-331,
2013.
Sakashita N, Kagawa S, Date R, Ueno T, Nakagawa T, Yamashita T, Obayashi
K, Ohshima T, Ueda M, Horiguchi H, Ando Y, Takeya M. Marked cardiomegaly
in a patient with familial amyloidotic polyneuropathy after orthotopic
liver transplantation: a case study. Pathol Int 63: 260-265, 2013.
Tasaki M, Ueda M, Obayashi K, Koike H, Kitagawa K, Ogi Y, Jono H, Su Y,
Suenaga G, Oshima T, Misumi Y, Yoshida M, Yamashita T, Sobue G, Ando Y. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach. Int J Cardiol 170: 69-74, 2013.
Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Life Sci 93: 1017-1022, 2013.
Usuku H, Obayashi K, Shono M, Oshima T, Tasaki M, Yasuda H, Ogawa H, Ando Y. Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy. Amyloid 20: 251-255, 2013.
Wixner J, Obayashi K, Ando Y, Karling P, Anan I. Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis. Amyloid 20: 99-106, 2013.
2012年
Obayashi K, Ueda M, Oshima T, Kawahara S, Misumi Y, Yamashita T, Jono H,
Yazaki M, Kametani F, Ikeda S, Ohya Y, Asonuma K, Inomata Y, Ando Y. Pathological
changes long after liver transplantation in a familial amyloidotic polyneuropathy
patient. BMJ Case Rep, bcr2012006593, 2012.
Obayashi K, Ando Y. Focus on autonomic dysfunction in familial amyloidotic polyneuropathy. Amyloid 19 (Suppl 1): 8-10, 2012.
Motomiya Y, Uji Y, Ando Y. Capillary electrophoretic profile of β2-microglobulin intermediate associated with hemodialysis. Ther Apher Dial 16: 350-354, 2012.
Su Y, Misumi Y, Ueda M, Shono M, Tasaki M, Guo J, Jono H, Obayashi K, Senokuchi T, Yamagata K, Ando Y. The occurrence of islet amyloid polypeptide amyloidosis in Japanese subjects. Pancreas 41: 971-973, 2012.
Asonuma K, Ohya Y, Isono K, Takeichi T, Yamamoto H, Lee KJ, Okumura K, Ando Y, Inomata Y. Current state of domino transplantation in Japan in terms of surgical procedures and de novo amyloid neuropathy. Amyloid 19 (Suppl 1): 75-77, 2012.
Jono H, Anno T, Motoyama K, Misumi Y, Tasaki M, Oshima T, Mori Y, Mizuguchi
M, Ueda M, Shinriki S, Shono M, Obayashi K, Arima H, Ando Y. Potential
use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for
familial amyloidotic polyneuropathy. Amyloid 19 (Suppl 1): 50-52, 2012.
Ando Y. A report on VIIIth international symposium on familial amyloidotic
polyneuropathy and VIIth international symposium on liver transplantation
in familial amyloidotic polyneuropathy. Amyloid 19 (Suppl 1): 1-2, 2012.
Berk JL, Suhr OB, Sekijima Y, Yamashita T, Heneghan M, Zeldenrust SR, Ando Y, Ikeda S, Gorevic P, Merlini G, Kelly JW, Skinner M, Bisbee AB, Dyck PJ, Obici L; Familial Amyloidosis Consortium. The Diflunisal Trial: study accrual and drug tolerance. Amyloid 19 (Suppl 1): 37-38, 2012.
Yamashita T, Ando Y, Okamoto S, Misumi Y, Hirahara T, Ueda M, Obayashi K, Nakamura M, Jono H, Shono M, Asonuma K, Inomata Y, Uchino M. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology 78: 637-643, 2012.
Ueda M, Ageyama N, Nakamura S, Nakamura M, Chambers JK, Misumi Y, Mizuguchi M, Shinriki S, Kawahara S, Tasaki M, Jono H, Obayashi K, Sasaki E, Une Y, Ando Y. Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: A valid pathological model of the human disease. Lab Invest 92: 474-484, 2012.
Misumi Y, Ueda M, Obayashi K, Jono H, Su Y, Yamashita T, Ohshima T, Ando Y, Uchino M. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy. Hum Pathol 43：96-104, 2012.
Misumi Y, Ueda M, Obayashi K, Jono H, Yamashita T, Ando Y. Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy. Amyloid 19 (Suppl 1): 8-10, 2012.
Hayashi Y, Mori Y, Higashi T, Motoyama K, Jono H, Sah DW, Ando Y, Arima H. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy. Amyloid 19 (Suppl 1): 47-49, 2012.
Hayashi Y, Mori Y, Yamashita S, Motoyama K, Higashi T, Jono H, Ando Y, Arima H. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy. Mol Pharm 9: 1645-1653, 2012.
Su Y, Jono H, Torikai M, Hosoi A, Soejima K, Guo J, Tasaki M, Misumi Y,
Ueda M, Shinriki S, Shono M, Obayashi K, Nakashima T, Sugawara K, Ando
Y. Antibody therapy for familial amyloidotic polyneuropathy. Amyloid 19
(Suppl 1): 45-46, 2012.
Ando Y, Ueda M. Diagnosis and therapeutic approaches to transthyretin amyloidosis. Curr Med Chem 19: 2312-2323, 2012.